Fluorodeoxyglucose (FDG)
A PET Scan uses a small amount of a radioactive tracer (drug) to show difference between healthy and cancer tissue.
The role of this procedure is to detect the metabolically active malignant lesions including lung cancer, breast cancer, colorectal cancer, hepatic carcinoma, ovarian cancer, multiple myeloma, melanoma, brain cancer.
Before PET scan, a mall amount of FDG is injected into the patient. Because cancer cells grows at a faster than healthy tissue. cancer cells absorb more of the FDG.
Fluorodeoxyglucose (18F)
Melting point- 170 to 176⁰C (338 to 349⁰F, 443 to 449 ⁰ K)
A PET Scan uses a small amount of a radioactive tracer (drug) to show difference between healthy and cancer tissue.
The role of this procedure is to detect the metabolically active malignant lesions including lung cancer, breast cancer, colorectal cancer, hepatic carcinoma, ovarian cancer, multiple myeloma, melanoma, brain cancer.
Before PET scan, a mall amount of FDG is injected into the patient. Because cancer cells grows at a faster than healthy tissue. cancer cells absorb more of the FDG.
Fluorodeoxyglucose (18F)
IUPAC Name- 2-Deoxy-2-[¹⁸F]fluoroglucose
Chemical formula- C₆H₁₁¹⁸FO₅
Molar mass- 181.1495 g mol͍ㄧ¹Melting point- 170 to 176⁰C (338 to 349⁰F, 443 to 449 ⁰ K)
No comments:
Post a Comment